The mission of the BioNJ Clinical Trials Committee is to foster communication, education, and collaboration among BioNJ members involved with all aspects of clinical research.
Please Click Here to participate in our survey and help shape future programs.
October 5, 2011: Clinical Trials Breakfast Briefing
Ülo Palm, M.D., Ph.D., M.B.A., ASQ-CMQ/OE, Senior Vice President Clinical Operations & Biometrics, Forest Laboratories, Inc., Committee Chair
John Morel, CPCU, ARM, Vice President, Business Devlopment, Berkley Life Sciences, LLC
Michael Trapani, Senior Consultant, Biologics Consulting Group, Inc.
Andrew Brooks, Ph.D., Chief Operating Officer, RUCDR Infinite Biologics
Denise Dennie, Pharm.D., R.Ph., P.M.P, Head, BD-Drug Disposition, Safety & Animal Research, Sanofi
Rob Ott, M.B.A., Director of Business Operations, ACT Oncology
Sreekant Murthy, Ph.D., Chief Research Compliance Officer, Rowan University
Marie-Agnes Patrone-Michellod, Ph.D., Manager, Regulatory Affairs & Marketing, Cancer Genetics, Inc.
If you are interested in becoming a sponsor of the BioNJ Clinical Trials Committee, please contact Kathleen Otto at KOtto@BioNJ.org or by phone at 609-890-3185.